RecruitingNCT07052604
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Sponsor
Centre Hospitalier de Saint-Denis
Enrollment
300 participants
Start Date
Dec 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Adult patients (age ≥ 18 years)
- Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023
- Intubated and mechanically ventilated
- Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
Exclusion Criteria2
- Patients under 18 years old
- Patients who refuse the use of their data for research purposes
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07052604
Related Trials
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
NCT059253091 location
Prediction of Postoperative ICU Requirement in Oncologic Surgery
NCT075429251 location
VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024
NCT071818241 location
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
NCT0724003839 locations
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
NCT058437869 locations